Duodenal Mucosal Resurfacing

Adults with obesity and type 2 diabetes had reductions in body weight and HbA1c 1 year after undergoing an endoscopic procedure that resurfaces the duodenum lining, according to top-line results from a real-world registry study.

The FDA granted breakthrough device designation to an endoscopic procedure that resurfaces the duodenum lining to help people maintain weight loss after discontinuing GLP-1 receptor agonist treatment, according to a press release.

The FDA granted breakthrough device designation for an endoscopic procedure that resurfaces the duodenum lining to allow for weight maintenance after discontinuation of a GLP-1 receptor agonist, according to an industry press release.

A first-in-class duodenal mucosal resurfacing therapy is associated with reductions in HbA1c and body weight at 24 weeks among a cohort of insulin-treated adults with type 2 diabetes, according to a company press release.

Cultural diets, like the Mediterranean diet, are beneficial for people with diabetes, so it is important to incorporate culturally relevant foods into meal plans, according to experts.

The FDA granted breakthrough device designation for a first-in-class duodenal mucosal resurfacing intervention for adults with insulin-treated type 2 diabetes, according to an industry press release.

Adding liraglutide and lifestyle counseling to duodenal mucosal resurfacing eliminated the need for insulin therapy in most patients with type 2 diabetes through 18 months, according to data from a feasibility study.